Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.
about
Histone methyltransferases: novel targets for tumor and developmental defectsNew insights into establishment and maintenance of DNA methylation imprints in mammalsStructure and function of dioxygenases in histone demethylation and DNA/RNA demethylationFlavin-dependent enzymes in cancer preventionMolecular Mimicry and Ligand Recognition in Binding and Catalysis by the Histone Demethylase LSD1-CoREST ComplexLSD2/KDM1B and Its Cofactor NPAC/GLYR1 Endow a Structural and Molecular Model for Regulation of H3K4 DemethylationStructure-function analysis reveals a novel mechanism for regulation of histone demethylase LSD2/AOF1/KDM1bThe Methyltransferase NSD3 Has Chromatin-binding Motifs, PHD5-C5HCH, That Are Distinct from Other NSD (Nuclear Receptor SET Domain) Family Members in Their Histone H3 RecognitionStructural insight into substrate recognition by histone demethylase LSD2/KDM1bDeciphering the Epigenetic Code in Embryonic and Dental Pulp Stem CellsKDM1 class flavin-dependent protein lysine demethylasesBase excision repair facilitates a functional relationship between Guanine oxidation and histone demethylationKDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcriptionNSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.Modulation of chromatin remodelling induced by the freshwater cyanotoxin cylindrospermopsin in human intestinal caco-2 cells.Transcriptional regulation of the albumin gene depends on the removal of histone methylation marks by the FAD-dependent monoamine oxidase lysine-specific demethylase 1 in HepG2 human hepatocarcinoma cellsHBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulatorsRegulation of histone H3K4 methylation in brain development and disease.Small-molecular modulators of cancer-associated epigenetic mechanisms.Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexesNeural crest specification and migration independently require NSD3-related lysine methyltransferase activity.In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.Transcription driven somatic DNA methylation within the imprinted Gnas clusterBalancing histone methylation activities in psychiatric disorders.Dynamic CpG island methylation landscape in oocytes and preimplantation embryosA chromatin activity-based chemoproteomic approach reveals a transcriptional repressome for gene-specific silencing.Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2Targeting protein lysine methylation and demethylation in cancers.Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiationGenomic imprinting: recognition and marking of imprinted loci.Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancerDeep sequencing and de novo assembly of the mouse oocyte transcriptome define the contribution of transcription to the DNA methylation landscapeHepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing.The LSD1 Family of Histone Demethylases and the Pumilio Posttranscriptional Repressor Function in a Complex Regulatory Feedback LoopDynamic changes in histone modifications precede de novo DNA methylation in oocytes.Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.
P2860
Q26775027-03B44537-EF90-46C1-90D2-FB9996F08C37Q26852971-D430AAB6-7909-4B46-BCC3-18FF8F658EC5Q27012506-EF9EF65A-F268-4B43-BB65-4671136260B4Q27023514-9F834D23-CEF0-4074-A94D-E6EA723DF3A5Q27666875-64E8C9A0-CA09-42BD-A830-516375C9C888Q27675574-048FF01B-9DEA-4278-BA62-9A18509B608CQ27675595-56C9FE82-22A3-46B4-A031-6FFD91EBE5DAQ27675605-A1DF8008-7A81-4717-A865-91CCB706871DQ27676033-37E65906-79AC-48B3-AD95-773D681852A9Q28080288-A7B67662-CAAB-4E71-B8C5-B6DCA56BC702Q28084876-FFFBCDE9-B1FF-4492-AAF5-7712F5B3D0CFQ28283078-64B1D01A-465A-4111-B3B9-874FA7B7C31CQ28513535-E9EA0190-611D-45EE-B1D1-0B53630671B4Q30586112-0568ED23-34E3-4669-96B7-EC6E9038D549Q33710042-522D8D17-271A-4643-9854-0CA4121BAC7FQ33749005-5AFF624D-092C-411E-BD61-B51DA056C1A9Q33752169-1D040127-73F3-4BB9-8A9D-FB8176689129Q33853890-537A4BF2-828D-4FBC-AEE1-25C7F35AAF14Q34079415-22883B0D-5FD6-46C3-929D-BD4C332DA8EAQ34628002-EC96F863-2E20-4B29-955A-445D27D0971BQ34667055-7A69586F-B0DE-4138-B4C3-7883BF544198Q34680417-2FAEF4C8-D933-4620-8AF4-A582AE4C61ABQ34789373-9B27D472-775B-4CED-98BC-242A74366F20Q35057896-430C77FD-F7BC-450B-8CF4-629BD10C9796Q35100274-AB32A31B-88AF-48C4-8FD8-B10E50BF0B78Q35135165-96497DA1-0F41-43FD-A449-BB8C359785E7Q35180203-0F56C6FA-36C1-4BFA-9E79-7CF3B10983E8Q35587244-891C8844-A3F8-4480-990E-3332B76968F0Q35609473-66124860-F5AB-4033-8314-7DA440B5B6C2Q35629831-C1606398-3F86-4836-88EE-4A3E1C258AF3Q35787101-7423D76F-9F24-4CA4-BBE8-56A07CF52044Q35857104-608AEBD4-0F21-4F8E-924B-AAA24721B0A6Q36067023-9520FBF1-7410-4B68-B587-751E56362689Q36092232-A52DD71F-3BD8-4097-944E-D03579280117Q36187854-687EA74D-75D8-46A5-A65A-65FAF08EC790Q36289563-A88E7E59-60B5-4634-B6DD-FE86B6112DFFQ36406402-50911D58-6FEE-495E-9CCF-5F793D65458DQ36474544-871C5F96-E286-4EA3-81C5-433B2515C7F0Q36495170-E502804C-137D-442A-AE25-BECE2E7E5527Q36914209-865C5E1E-0781-4FA6-93A5-55A95B9C008A
P2860
Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@ast
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@en
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@nl
type
label
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@ast
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@en
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@nl
prefLabel
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@ast
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@en
Human LSD2/KDM1b/AOF1 regulate ...... ntragenic H3K4me2 methylation.
@nl
P2093
P2860
P1433
P1476
Human LSD2/KDM1b/AOF1 regulate ...... intragenic H3K4me2 methylation
@en
P2093
Andrew J Barbera
Christine Lian
Dongmei Cheng
Guangchao Sui
Guo-Cheng Yuan
Junmin Peng
Michael Rutenberg
P2860
P304
P356
10.1016/J.MOLCEL.2010.07.008
P50
P577
2010-07-01T00:00:00Z